European Companies Search Engine
EU funding (€22.8M): Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861 Hor1 Dec 2014 EU Research and Innovation programme "Horizon"
Text
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "Centre Muraz - EU funding (€22.8M): Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
